HOXA9 and glioma: HOXA9 was found to be highly overexpressed in a subset of GBM patients comparing to lower grades glioma (LGG, WHO grades II/III) patients and normal controls (Figure 1A), confirming that HOXA9 is associated with glioma grade and may be important in tumor progression.